期刊文献+

原发性中枢神经系统恶性淋巴瘤54例临床分析 被引量:9

Clinical Study of Primary Central Nervous System Lymphoma: 54 Cases of Reports
暂未订购
导出
摘要 目的 :提高对原发性中枢神经系统恶性淋巴瘤 (PCNSL)临床特征的认识。方法 :回顾性分析经病理证实的 5 4例PCNSL。结果 :该肿瘤多发生于中老年患者 ,性别无明显差异 ;好发于幕上 ,临床上无特征性表现。5 4例中获随访 4 9例。随诊期 3~ 14 3个月 ,平均 31个月 ,中位数为 2 0个月。其中EERC、PRRC、XC、RC、ST五组的中位生存时间分别为 2 2、 19、 2 1、 17、 9个月。其中EERC、PRRC、XC、RC四组间差异无显著性 (P均 >0 5 ) ,ST组同其他四组对数秩检验差异显著 (P均 <0 0 5 )。结论 :原发性中枢神经系统恶性淋巴瘤术前难以确诊 ,预后不良。手术的主要目的是解除肿瘤引起的颅内高压 ,减轻或解除脑神经功能的进一步废损 ,明确诊断。强调术后常规放疗和化疗 。 Objective:To have a better understanding of the clinical characteristics of primary central nervous system lymphoma(PCNSL).Methods∶The clinical data of 54 patients with PCNSL were studied retrospectively.Results∶PCNSLs ofen occurred in adults and aged patients, no signifi cant difference in sex;and the majority of PCNSLs were found in supratentorial reg ion of cranial cavity.Forty-nine of 54 cases were followed up,28 cases are still alive and 5 cases were missing.The time of follow-up was from 3 to 143 months,the averag e was 31 months and the median is 20 months.The mean lifetime of the group performed entire tumor excision and accepted radiotherapy and chemothe rapy(EERC) was 22 months,the group underwent partial tumor resection and received radiotherapy and chemotherapy(PRRC) was 19 months, the group had X-knife and c hemotherapy(XC) was 21 months, the group accepted radiotherapy and chemotherapy(RC) was 17 months,the group merely received surgical therapy (ST) was 9 months.No significant difference in the mean lifetime wsa observed between EERC and PRR C,EERC and XC,EERC and XC,PRRC and RC,PRRC and RC,XC and RC( P >0 05).The group between ST and EERC,PRRC XC,RC had significant relation in the mean lifetime( P <0 05).Conclusion∶It is difficult to diagnose the PCNSL before operation and the prognosis of this disease is poor. T he main objective of surgical therapy is to relieve the intracranial hypertension and the further damage to cranial nerve function caused by the tumor and darity t he final di agnosis.Emphasizing regular poctopeictive radiotherapy and chemotherapy;wa s the crux of prolongation of the liftime and improvement of the qualit y of life.
出处 《华西医学》 CAS 2002年第1期19-21,共3页 West China Medical Journal
关键词 淋巴瘤 脑肿瘤 手术治疗 放疗 化疗 s:lymphoma brain tumor surgical therapy radiotherapy chemotherapy
  • 相关文献

参考文献7

  • 1于如同,李能德,毛伯镛.原发性椎管内恶性淋巴瘤[J].中国肿瘤临床与康复,1997,4(3):29-30. 被引量:4
  • 2Schlegel U,Schmidt-Wolf IG,Deckert M.Primary CNS lymphoma:clinical presentation,pathological classification,molecular pathogenesis and treatment[J].J Neyrol Sci 2000;181(1-2):1-12.
  • 3Gallatin VM,Weissman IL,Butchec FL.A cell-surface molecule involved in organ-specific homing of lymphocytes[J].Nature.1983;304:30.
  • 4Hochberg FH,Miller DC.Primary central nervous system lymphoma[J].J Neurosurg,1988;68:835.
  • 5Schlegel U,Pels H,Glasmacher A,et al.Combined systemic and intraventricular chemotherapy in primary CNS lymphoma:a pilot study[J].J Neurol Neurosurg Psychiatry 2001;71(1):118-122.
  • 6Lal P,Haldar,S,Datta NR,et al.Primary CNS lymphoma:an audit of cases treated over a nine year period and review of the literature[J].Indian J Cancer 2000 Mar;37(1):32-42.
  • 7Kawamura T,Koga S,Okamoto M,et al.Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system(CNS)[J].Radiat Med 2001;19(3):145-149.

共引文献3

同被引文献74

  • 1吴康智,杨建民,宋献民,许小平,侯军,王健民.原发性中枢神经系统淋巴瘤临床和病理分析[J].第二军医大学学报,2004,25(6):687-688. 被引量:4
  • 2胡毅,冯奉仪,石远凯,周立强,顾大中,王奇璐.原发性中枢神经系统淋巴瘤28例临床分析[J].中华肿瘤杂志,2004,26(6):375-378. 被引量:22
  • 3汪清铭,吴祥元,王东宁,林曲,董敏,温景芸.B细胞淋巴瘤SHP-1基因甲基化状态及其意义[J].中山大学学报(医学科学版),2007,28(1):92-96. 被引量:4
  • 4张斌,毛庆,栗洁,孟志勇,贾丛林,江建军.中枢神经系统原发性淋巴瘤32例临床分析[J].中国实用神经疾病杂志,2007,10(1):42-43. 被引量:1
  • 5王奇璐 主编.恶性淋巴瘤的诊断与治疗[M].北京:北京医科大学协和医科大学联合出版社,1996.346.
  • 6Coulon A,Lafitte F,Hoang-Xuan K,et al.Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients[J].Eur Radiol,2002,12(2):329-340.
  • 7Ferreri AJ,Abrey LE,BlayJY,et al.Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma,Lugano Switzerland,June 12 to 15,2002[J].J Clin Oncol,2003,21(12):2407-2414.
  • 8Diamond C,Taylor TH,Aboumrad T,et al.Changes in acquired irnmunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy:incidence,presentation,treatment and survival[J].Cancer,2006,106(1):128-135.
  • 9Olson JE,Jarmey CA,Ran RD,et al.The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma:a surveillance,epidemiology,and end results analysis[J].Cancer,2002,95(7):1504-1510.
  • 10Alba O,Weitzaman S.Primary central nervous system lymphoma in children[J].Neurosurg Focus,2006,21(5):E8.

引证文献9

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部